Is there an Exposure–Response Relationship for Nivolumab in Real-World NSCLC Patients?

Pharmacokinetic/pharmacodynamic data from real-world cohort are sparse in non small–cell lung cancer (NSCLC) patients treated with nivolumab. The aim of this prospective observational study was to explore the exposure-response relationship for effectiveness and toxicity of nivolumab in 81 outpatient...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellesoeur, Audrey, Ollier, Edouard, Allard, Marie, Hirsch, Laure, Boudou-Rouquette, Pascaline, Arrondeau, Jennifer, Thomas-Schoemann, Audrey, Tiako, Manuela, Khoudour, Nihel, Chapron, Jeanne, Giraud, Frédérique, Wislez, Marie, Damotte, Diane, Lupo, Audrey, Vidal, Michel, Alexandre, Jérôme, Goldwasser, François, Tod, Michel, Blanchet, Benoit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895963/
https://www.ncbi.nlm.nih.gov/pubmed/31766292
http://dx.doi.org/10.3390/cancers11111784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895963/
https://www.ncbi.nlm.nih.gov/pubmed/31766292
http://dx.doi.org/10.3390/cancers11111784

Ejemplares similares